Effect of Duloxetine 60 mg to 120 mg Once Daily in Patients with Chronic Low Back Pain

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-003484-31

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to assess the efficacy of duloxetine 60 mg once daily (QD) to 120 mg QD compared with placebo on the reduction of pain severity as measured by the weekly mean of the 24-hour average pain scores in patients with chronic low back pain (CLBP) during a 13-week, double-blind acute treatment period using an 11-point Likert scale and an electronic patient diary.


Critère d'inclusion

  • Chronic Low Back Pain